According to the new market research report by IndustryARC titled “ [FURL=https://www.industryarc.com/PressRelease/225/omega-3-pufa-market-research-analysis.html] Omega 3 PUFA Market[/FURL] : By Type (DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid), and ALA (Alpha-linoleic acid)) Source (Marine, Plant) Form (Oils, Capsules, Powder) Application (Dietary Supplements, Pharmaceuticals, Infant Foods, F&B) – Forecast (2018-2023)”, the market is mainly driven by the widespread consumer awareness and considerable demand for omega 3 based products.Raw materials for fish oil, flaxseed oil, algal oil manufacturing is supplied by the fisheries and farms. Oils are extracted using various techniques such as wet pressing for fish oil, and solvent extraction are used for extraction of oil from flaxseed. These oils are sent to the concentrate and ingredient manufacturers who employ advanced scientific techniques to extract Omega-3 PUFA ingredients. Omega-3 PUFA ingredients are used as additives in various products such as infant foods, pharmaceutical API, pet feed, dietary supplements, and functional foods. These omega-3 fortified products are made available to consumers through retail chains.
The growing popularity of DHA as an essential nutrient for infants coupled with recommendations by the health institutes drives the market for omega 3 PUFA ingredients in infant formulae and baby food products.
A rapidly aging population coupled with growing concern about cardiovascular health is a key growth factor that is driving significant growth for the market.
The market for omega 3 in the pharmaceutical industry is primarily driven by the increasing R&D efforts to formulate and develop new EPA/DHA concentrates which are used as APIs in drugs.
View Full Table Of Content Of Omega 3 PUFA Market
[FURL]https://www.industryarc.com/Report/7466/omega-3-pufa-market.html[/FURL]
Key Players of the Omega 3 PUFA Market:
The key players in the market include Croda International PLC (U.K.), Royal DSM (The Netherlands), Aker BioMarine ASA (Norway), BASF SE (Germany) and FMC Corporation (U.S.). New flavors of IncromegaTM 3mulsionTM DHA 2.0 were launched by Croda to strengthen its product portfolio in DHA concentrates for children and aged people.
About IndustryARC:
IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.